Latest DEF 14A proxy statements

Quince Therapeutics announces its 2026 Annual Meeting, seeking shareholder approval for a reverse stock split to maintain Nasdaq compliance.

Bio Green Med Solution, Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 18, 2026, to be held via a virtual-only format.

Alliance Laundry Holdings Inc. has issued its 2026 proxy statement detailing director elections, executive compensation advisory votes, and auditor ratification.

Nuvectis Pharma, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026.

SandRidge Energy, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and a proposal to extend its Omnibus Incentive Plan.

HubSpot's 2026 Proxy Statement outlines director elections, executive compensation, and a proposed amendment to the 2024 Stock Option and Incentive Plan.

Traeger, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation updates.

Payoneer Global Inc. has released its 2026 Proxy Statement, detailing the upcoming Annual Meeting of Stockholders on June 9, 2026, and outlining key governance, compensation, and director election proposals.

Spero Therapeutics, Inc. has issued its 2026 proxy statement detailing proposals for director elections, executive compensation, and a significant increase in authorized common stock.

Abeona Therapeutics Inc. has issued its 2026 proxy statement detailing proposals for director elections, executive compensation, and an increase in equity incentive plan shares.

Sallie Mae's 2026 proxy statement outlines director elections, executive compensation, and strategic initiatives following a strong 2025 performance.

Gyre Therapeutics schedules its 2026 Annual Meeting for June 10, 2026, to vote on director elections, executive compensation, auditor ratification, and the conversion of Series B Preferred Stock related to the Cullgen merger.

Serina Therapeutics has scheduled its 2026 Annual Meeting for June 17, 2026, to address key capital structure, equity incentive, and governance proposals.

Butterfly Network, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting of stockholders to be held virtually on June 18, 2026.

OceanFirst Financial Corp. has released its 2026 proxy statement detailing the upcoming annual meeting, executive compensation, and the proposed 2026 Stock Incentive Plan.

Sensei Biotherapeutics seeks stockholder approval for post-acquisition governance, share authorization, and equity plans following its merger with Faeth Therapeutics.

SCYNEXIS, Inc. has scheduled a special meeting for May 19, 2026, to seek stockholder approval for a reverse stock split to regain compliance with Nasdaq minimum bid price requirements.

Krispy Kreme's 2026 proxy statement outlines board changes, executive compensation, and proposals for the upcoming annual meeting.

Target Corporation has released its 2026 Proxy Statement, detailing the agenda for its upcoming Annual Meeting of Shareholders, including director elections, executive compensation, and shareholder proposals.

Coupang, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and executive compensation.

Vivid Seats Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors and ratify auditor appointments.

Standard BioTools Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026, with several key proposals for shareholder vote.

Seritage Growth Properties announces its 2026 Annual Meeting of Shareholders, detailing trustee elections, executive compensation, and auditor ratification.

Balchem Corporation has issued its 2026 Proxy Statement, inviting shareholders to its virtual Annual Meeting on June 18, 2026, to vote on director elections, auditor ratification, and executive compensation.

Functional Brands Inc. is holding a special meeting on May 28, 2026, to vote on a reverse stock split and a new equity incentive plan.

The RealReal, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, and is proposing several amendments to its Certificate of Incorporation, including phasing out its classified board structure.

GeoVax Labs announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, warrant exercise approvals, and auditor ratification.

Armata Pharmaceuticals, Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for June 11, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.

Aldeyra Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 9, 2026, to elect directors, ratify auditor appointments, and vote on executive compensation.

Biomea Fusion, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, to elect directors and ratify auditor appointment.